Gemcitabine in cervical cancer.

Gynecologic oncology

Volumn 90, Issue 2 Pt 2, 2003, Pages

  Mutch, David G ^a   Bloss, Jeffrey D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CISPLATIN; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE;

ADJUVANT THERAPY; FEMALE; HUMAN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; REVIEW; TUMOR RECURRENCE; UTERINE CERVIX TUMOR;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; DEOXYCYTIDINE; FEMALE; HUMANS; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; UTERINE CERVICAL NEOPLASMS;

MLCS; MLOWN;

EID: 17144453674     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0090-8258(03)00338-x     Document Type: Review

References (37)